Remedium Lifecare Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024
For the full year, sales was INR 40,417.07 million compared to INR 5,098.37 million a year ago. Revenue was INR 40,627.88 million compared to INR 5,098.37 million a year ago. Net income was INR 327.3 million compared to INR 54.26 million a year ago. Basic earnings per share from continuing operations was INR 22.73 compared to INR 0.1346 a year ago. Diluted earnings per share from continuing operations was INR 22.73 compared to INR 0.1346 a year ago.